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According to the current paradigm, the white adipose tissue (WAT) not only releases 
fatty acids, cholesterol, retinoids and other lipids stored in the adipocytes, but also pro-
duce and secrete numerous signaling proteins collectively termed adipokines. Among 
them are various cell growth factors such as nerve growth factor (NGF) and brain-de-
rived growth factor (BDNF). While literature around obesity and its related diseases is 
abundant, we still do not know how WAT behaves during normal development. In the 
present study, we explored the expression of NGF and BDNF in the peripancreatic fat 
tissue (Ppf ) and the epididymal fat tissue (Epf ) during a critical period for the metabolic 
maturation of male Wistar rats. At birth almost no abdominal WAT was observed in the 
rats. From day 15 to adulthood (2 months), it increased in weight. However, the adipo-
cyte diameter was not different during the first month, compared to adulthood, indi-
cating that the tissue growth in this stage was mostly hypertrophic, while in the second 
month we also observed hyperplasia of the adipocytes. We measured the production 
of the neutrophins NGF and BDNF by the abdominal WAT depots. We observed a sig-
nificant reduction in the expression of NGF in Epf at 28d and two months. However, 
NGF expression in Ppf remained stable from postnatal 15d to adulthood, except for a 
nadir at 28d. On the other hand, we failed to detect BDNF during the first 2 months of 
life in Ppf, but it was expressed at detectable amounts in Epf, peaking at day 20. We do 
not know how these secretory changes influence the development of the cells and the 
surrounding tissues. However, in obesity the amount of WAT is increased, and it is nec-
essary to understand the mechanisms of WAT growth in physiological state to identify 
with the unbalance in this tissue present in obesity.  
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introduction
White adipose tissue (WAT) plays an 
important role in nutrient metabo-
lism, increasing the triglycerides stor-
age during caloric intake, and releas-
ing fatty acids when energy intake 
exceeds the energy expenditure (1). 
WAT is an endocrine and paracrine 
organ, which synthesizes and releases 
different pro- and anti-inflammatory 
cytokines known as adipokines or adi-
pocytokines (reviewed in 2). 
Neurotrophins, such as nerve 
growth factor (NGF) (3) and brain-
derived neurotrophic factor (BDNF) 
(4), are synthesized in many cell types, 
including adipocytes. These neurotro-
phins exert multiple actions on mul-
tiple cells from the neural, endocrine, 
immune and cardiovascular systems 
(5-7). It has been shown that NGF 
may function as a guide for the sym-
pathetic fibers and blood vessels to 
the pancreatic islets in early develop-
mental stages of the pancreas, and also 
maintain beta-cell innervation in later 
stages of life (6). Neurotrophins also 
induce metabotrophic changes in glu-
cose and lipids homeostasis (7). Actu-
ally, the changes in NGF and BDNF 
secretion by WAT, and their possible 
physiological roles during develop-
Adipobiology 5, 2013
NGF and BDNF in adipose tissue40 ReseaRch aRticle
ment are not known. Interestingly, our group has also described 
a physiological hyperinsulinemic and hyperglycemic state dur-
ing the perinatal development of rats just before weaning, which 
precedes the metabolic maturation of these animals (8).
Here, we aimed to elucidate the expression profiles of NGF 
and BDNF in peripancreatic fat tissue (Ppf) and epididymal fat 
tissue (Epf) at different stages, comprising the above mentioned 
temporal window during the metabolic development of male 
Wistar rats.
Materials and Methods
Experimental animals and sample collection. Wistar rats were 
obtained from the local animal facility, maintained in a facility 
with a 12:12 h light-dark cycle (0600-1800), and allowed free 
access to standard laboratory rat diet and tap water. All methods 
used in this study were approved by the Animal Care Commit-
tee of the Instituto de Fisiología Celular, Universidad Nacional 
Autónoma de México. Animal care was kept according to the 
International Guiding Principles for Biomedical Research In-
volving Animals, Council for International Organizations of 
Medical Sciences, 2010. 
Ppf and Epf were obtained from fasted male Wistar rats of 15, 
20 and 28 days post birth (dpb), and 2 months old animals. Prior 
to surgery, the animals were anesthetized with an intraperitoneal 
injection of sodium pentobarbital (40 mg/Kg) and weighted. 
Adipose depots were immediately removed, washed with ice-
cold phosphate buffer saline (PBS, 0.1M pH 7.4), weighted and 
submerged in liquid nitrogen for subsequent isolation of total 
protein. Alternatively, adipose tissue samples were fixed during 
24 h at 4 ºC, in buffered solution of paraformaldehyde 4%.
Morphometric analysis. Previously fixed Ppf and Epf adipose 
tissues were submerged 24 h in 30% sucrose, mounted in tissue-
tek (Sakura finetek USA Inc) and stored at -70 0C until use. Tissue 
samples were cut in 20 mu thick sections using a cryostat. Images 
were obtained and digitalized using a microscope Leica Micro 
Dissection System DM6000 B/DM6000 M, coupled to a Hitachi 
HV-D20 camera. Fifteen to 25 random fields were taken for each 
adipose depot and the diameter of 400 to 500 adipocytes per ani-
mal were measured using the ImageJ (1.38X) software.
NGF and BDNF determination in adipose depots. Quantifica-
tion of both neurotrophins was carried out with total protein 
homogenates from Ppf and Epf adipose tissues. Briefly, 300 to 
500 mg of fresh tissue were placed in TE buffer (250 mM Tris, 
1 mM EDTA pH 8 with complete protease inhibitors cocktail; 
Roche, Inc), frozen in liquid nitrogen and dispersed by me-
chanical action. The homogenates were centrifuged at 12000 g 
and 4°C for 5 min, and the supernatants were used for analysis 
of NGF (DuoSet ELISA development system for rat beta-NGF, 
R&D systems) and BDNF (BDNF Emax immunoassay system, 
Promega) by an enzyme-linked immunosorbent assay (ELISA) 
kit according to the manufacturer’s instructions. Total protein 
concentration was determined spectrophotometrically using a 
Nanodrop (Thermo scientific) and measuring the absorbance at 
a wavelength of 280 nm. The levels of NGF were expressed as ng/
mg of total protein and BDNF as pg/mg of total protein.
Statistical analysis. Data are expressed as means ± standard 
error of the mean (SEM). An analysis of variance (ANOVA) was 
performed to assess the statistical differences amongst groups 
(Stat view 4.57; Abacus Concepts, Cary, NC). Threshold of sig-
nificance was defined at p ≤ 0.05.
results
Morphometric analysis of peripancreatic and epididymal 
adipose tissue during the postnatal growth
The variation in the amount of mediators released by adipose 
tissues could impact on several physiological processes. A possi-
ble cause for a change in circulating neurotrophins could be for 
instance, an alteration of the proportion of adipose tissue with 
respect to the total weight of the animals. The morphometric 
properties of both adipose depots at different ages are shown in 
Table 1. At birth almost no abdominal WAT was observed in 
the rats. From day 15 to adulthood (2 months), it increased in 
weight, which was also reflected in a weight increase in Ppf and 
Epf. However, the adipocyte diameter was not different during 
the first month, compared to adulthood, indicating that the tis-
sue growth in this stage was mostly hypertrophic, while in the 
second month we also observed hyperplasia of the adipocytes.
No differences were observed between Ppf and Epf during the 
first 28 days of life. The weights in both fat depots in young adult 
rats (2 months) were higher, compared to the other ages studied. 
Moreover, the weight of Epf depot was higher than that observed 
in Ppf depot (p ≤ 0.05). This growth could arise from an increase 
in the number (hyperplasia) and/or the size (hypertrophy) of the 
adipocytes. Adipocyte diameter in Ppf and Epf remained con-
stant amongst days 15, 20 and 28, but significantly increased in 
the adulthood (p ≤ 0.05). 
NGF and BDNF secretion in peripancreatic and epididymal 
adipose tissue during the postnatal growth
To explore the physiology of the adipocytes during the animal 
maturation, we studied the neurotrophin levels in these cells 
in the different developmental stages considered in the present 
study. Figure 1 shows that NGF levels peaked at days 15 and 20 
in Epf and Ppf. Nevertheless, the amount of this neurotrophin 
decreased at day 28 and remained stable at 2 months of age in 
both cases. Noteworthy, Epf presented higher levels of NGF with 
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Figure 2. Amount of BDNF derived from peripancreatic (Ppf ) 
and epididymal (Epf ) fat at different developmental stages, 
same details and methods as in Figure 1. The data represent 
the mean ± sEM and normalized with respect to total protein, 
from at least three independent experiments in duplicate.  ++ 
p ≤ 0.05 with respect to the same adipose tissue of the previ-
ous age. N = 7 for 15, 20, 28 days and 2 months. BDNF was not 
detected in Ppf. 
Table 1. Weights and morphological characteristics of peripancreatic and epididymal white adipose depots during rat develop-
ment. *p ≤ 0.05 with respect to previous age. ++ p ≤ 0.05 with respect to peripancreatic fat at the same age. 
15 days 20 days 28 days 2 months
Body weight (g) 36.5 ± 0.6 51.1 ± 0.8* 78.7 ± 1.5* 269.9 ± 3.3*
Ppf weight (g) 0.025 ± 0.002 0.05 ± 0.002* 0 08 ± 0.005* 0.4 ± 0.02*
Epf weight (g) 0.037 ± 0.002 0.08 ± 0.003* 0.13 ± 0.005* 1.4 ± 0.11*++
Adipocyte diameter 
(mm)
Ppf 45.3 ± 0.7 47.5 ± 0.8* 46.48 ± 0.8* 50.9 ± 0.6*
Epf 44.9 ± 1.0 44.0 ± 0.8 46.29 ± 0.7* 54.2 ± 0.7*++
Figure 1.  Amount of NGF derived from peripancreatic (Ppf ) 
and epididymal (Epf ) fat at different developmental stages. 
Total protein was extracted from both adipose depots at 15, 
20 and 28 days post birth, as well as 2 months of age and were 
analyzed by ELIsA method. The data represent the mean ± 
sEM and normalized with respect to total protein, from at 
least three independent experiments in duplicate. *p ≤ 0.05 
with respect to peripancreatic fat in the same age; ++ p ≤ 0.05 
compared to same adipose tissue of the previous age. n=7 for 
15, 20, 28 days and 2 months. 
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respect to Ppf at all stages. On the other hand, BDNF (Fig. 2) 
reached a maximum at day 20 in Epf, then decreased at day 28 
and remained in the same level until 2 months. It seems that Ppf 
expresses very low levels or no BDNF, since its measurements 
were below the detection limit of the kit employed in this study.  
discussion 
Adipose tissue is a heterogeneous organ with biochemical and 
metabolic differences that depend on its anatomical location (9-
11). We found significant differences in the amount of NGF and 
BDNF in Ppf and Epf during development. Our findings show 
that NGF and BDNF levels were higher in Epf than in Ppf at all 
ages. This could be due to the metabolic status of each type of 
depot; for instance, rat Epf is rich in mitochondria and expresses 
a higher cytochrome-c oxidase activity compared, for example, 
to the inguinal adipose tissue (12).
Furthermore, we observed differences in the weight between 
Ppf and Epf. Thus, the amount of Epf was higher than the Ppf at 
all the studied ages. It has been observed that gonadal fat depots 
(such as epididymal, peritesticular, periovarian and periuterine) 
also increase with ageing (13). 
Our results are in agreement with previous reports, which 
demonstrated that during the postnatal development, there is an 
increase in the number and size of adipocytes as a function of 
energetic balance (caloric intake and energy expenditure) (14). 
It has been documented that WAT growth is depot- and species-
dependent (15), with visceral adipocytes generally larger than 
subcutaneous or intramuscular adipocytes (16). In humans, 
omental adipocytes are smaller than subcutaneous and other 
visceral adipocytes (17). It has been proposed that adipocyte size 
changes in relation to the cell lipid content, ranging from about 
30 to 130 mm in diameter and the volume of an adipocyte is a 
determinant of cell functionality with larger adipocytes gener-
ally exhibiting higher metabolic activity and secreting more che-
moattractants for immune cells (18). Our results demonstrate 
that during the first 28 days of life both depots grow, but the 
size of adipocytes remained quite stable, indicating hyperplasia. 
However in the adulthood both processes, hyperplasia and hy-
pertrophia, are present. 
NGF and BDNF are essential factors during the development 
of central and peripheral nervous system, playing roles in the 
control and regulation of different processes such as survival, 
apoptosis, proliferation, migration, differentiation, and synap-
tic plasticity, (reviewed in 5-7), also amyloid precursor protein 
processing and metabolism (see Viviana Triaca’s review in this 
volume of Adipobiology). Nevertheless, numerous reports have 
established that the action of NGF and BDNF are not restricted 
to the nervous system and can affect an extensive range of non-
neuronal tissues and processes such as inflammation, immu-
nity, and glucose and lipid metabolism (see 19). Ovary matura-
tion (reviewed in 20) as well as the morphogenesis of the testis 
and epididymis (21) requires the participation of NGF and/or 
BDNF. In addition, NGF exerts a variety of effects in the cardio-
vascular system. For example, the levels of this neurotrophin are 
decreased in atherosclerotic coronary vascular tissue, whereas 
increased in the subepicardial adipose tissue (22). Moreover, 
NGF possess angiogenic effects (23-26). Furthermore, in a re-
cent work Sornelli et al demonstrated that in animal models of 
stress and diabetes, the levels of NGF and BDNF produced by 
WAT and brown adipose tissue are significantly altered as com-
pared to control animals (27). 
We demonstrate that different amounts of NGF and BDNF 
are produced during postnatal development in Ppf and Epf de-
pots. These differences were marked during the first 2-4 weeks 
of age and decrease in adult stages. Thus both molecules could 
be involved in maturation and/or in morphogenetic events dur-
ing adipose tissue postnatal development. In addition, NGF (28) 
and/or BDNF could participate in the vascularization and/or 
sympathetic innervation of adipose tissue during development. 
The expression of these neurotrophins may contribute to differ-
ences in the amount, adipocyte size and functions of both adi-
pose depots. These hypotheses require to be further analyzed in 
future works.  
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